HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta-endorphin. Binding activity of synthetic analogs with various chain lengths in neuroblastoma x glioma NG108-15 cell membranes.

Abstract
Inhibition of binding of beta h-endorphin or Leu-enkephalin by beta h-endorphin analogs of various chain lengths in memmbrane preparations of the neuroblastoma x glioma NG108-15 cells has been investigated. The removal of even a single residue from the C-terminus results in the inability of the resulting peptide to completely displace beta h-endorphin. In addition, the proportion of nondisplaceable binding increases with decreasing chain length.
AuthorsR G Hammonds Jr, P Ferrara, C H Li
JournalInternational journal of peptide and protein research (Int J Pept Protein Res) Vol. 24 Issue 6 Pg. 597-9 (Dec 1984) ISSN: 0367-8377 [Print] Denmark
PMID6099337 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endorphins
  • Receptors, Opioid
  • Enkephalin, Leucine
  • beta-Endorphin
Topics
  • Animals
  • Cell Membrane (metabolism)
  • Endorphins (metabolism)
  • Enkephalin, Leucine (metabolism)
  • Glioma
  • In Vitro Techniques
  • Kinetics
  • Neuroblastoma
  • Rats
  • Receptors, Opioid (metabolism)
  • Structure-Activity Relationship
  • beta-Endorphin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: